Loading...
Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
BACKGROUND: Currently, there is no topical treatment available for any form of cutaneous leishmaniasis (CL) in most of the endemic areas. The aim of the current study was to develop a topical nano-liposomal Amphotericin B (AmB) for the treatment of CL. METHODOLOGY/PRINCIPAL FINDINGS: Liposomes conta...
Na minha lista:
| Udgivet i: | Int J Parasitol Drugs Drug Resist |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6904837/ https://ncbi.nlm.nih.gov/pubmed/31582344 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2019.09.004 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|